Your browser doesn't support javascript.
loading
Ramucirumab plus paclitaxel as a second-line treatment in HER2-positive gastric cancer: subgroup analysis of a nationwide, real-world study in Korea (KCSG-ST19-16).
Kim, Bum Jun; Jee, Hee-Jung; Rha, Sun Young; Han, Hye Sook; Ryu, Min-Hee; Park, Se Hoon; Kim, Jong Gwang; Bae, Woo Kyun; Lee, Keun-Wook; Oh, Do-Youn; Byun, Ji-Hye; Kim, Dong Sook; Suh, Young Ju; An, Hyonggin; Zang, Dae Young.
Affiliation
  • Kim BJ; Division of Hematology-Oncology, Department of Internal Medicine, Hallym University Medical Center, Hallym University College of Medicine, Anyang-si, Gyeonggi-do, 14068, Republic of Korea.
  • Jee HJ; Department of Biostatistics, Chungnam National University Sejong Hospital, Sejong, Republic of Korea.
  • Rha SY; Songdang Institute for Cancer Research, Yonsei University College of Medicine, Seoul, South Korea.
  • Han HS; Division of Medical Oncology, Department of Internal Medicine, Yonsei Cancer Center, Yonsei University College of Medicine, Seoul, South Korea.
  • Ryu MH; Brain Korea 21 PLUS Project for Medical Sciences, Yonsei University College of Medicine, Seoul, Republic of Korea.
  • Park SH; Department of Internal Medicine, Chungbuk National University Hospital, Cheongju, Republic of Korea.
  • Kim JG; Department of Internal Medicine, Chungbuk National University College of Medicine, Cheongju, Republic of Korea.
  • Bae WK; Department of Oncology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea.
  • Lee KW; Division of Hematology-Oncology, Department of Medicine, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea.
  • Oh DY; Department of Oncology/Hematology, School of Medicine, Kyungpook National University Chilgok Hospital, Kyungpook National University, Daegu, Republic of Korea.
  • Byun JH; Department of Internal Medicine, Chonnam National University Hwasun Hospital, Hwasun, Republic of Korea.
  • Kim DS; Department of Internal Medicine, Seoul National University Bundang Hospital, Seoul National University College of Medicine, 82 Gumi-ro 173 Beon-gil Bundang-gu, Seongnam, 13620, Republic of Korea.
  • Suh YJ; Department of Internal Medicine, Seoul National University Hospital, Seoul, Republic of Korea.
  • An H; Cancer Research Institute, Seoul National University College of Medicine, Seoul, Republic of Korea.
  • Zang DY; Innovation Research Department, Health Insurance Review and Assessment Service, Wonju, Republic of Korea.
Gastric Cancer ; 25(3): 609-618, 2022 05.
Article in En | MEDLINE | ID: mdl-35015188
Subject(s)
Key words
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Stomach Neoplasms / Adenocarcinoma Limits: Humans Country/Region as subject: Asia Language: En Journal: Gastric Cancer Journal subject: GASTROENTEROLOGIA / NEOPLASIAS Year: 2022 Type: Article
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Stomach Neoplasms / Adenocarcinoma Limits: Humans Country/Region as subject: Asia Language: En Journal: Gastric Cancer Journal subject: GASTROENTEROLOGIA / NEOPLASIAS Year: 2022 Type: Article